Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
Shiga toxin-producing <i>Escherichia coli</i>-associated hemolytic uremic syndrome (STEC-HUS) is a form of thrombotic microangiopathy secondary to an infection by an enterohemorrhagic <i>E. coli</i>. Historically considered a pediatric disease, its presentation has been descr...
Main Authors: | Benoit Travert, Cédric Rafat, Patricia Mariani, Aurélie Cointe, Antoine Dossier, Paul Coppo, Adrien Joseph |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/13/5/306 |
Similar Items
-
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
by: Adrien Joseph, et al.
Published: (2020-01-01) -
Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
by: Benoît Travert, et al.
Published: (2021-07-01) -
Red blood cell-derived arginase release in hemolytic uremic syndrome
by: Niklas Friberg, et al.
Published: (2024-01-01) -
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome
by: Piotr P. Avdonin, et al.
Published: (2023-12-01) -
Hemolytic uremic syndrome: Toxins, vessels, and inflammation
by: Howard eTrachtman
Published: (2014-11-01)